1
|
Maitisha G, Zhou J, Zhao Y, Han S, Zhao Y, Abliz A, Liu G. Network pharmacology-based approach to investigate the molecular targets of essential oil obtained from lavender for treating breast cancer. Heliyon 2023; 9:e21759. [PMID: 38034788 PMCID: PMC10681924 DOI: 10.1016/j.heliyon.2023.e21759] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2023] [Revised: 10/26/2023] [Accepted: 10/27/2023] [Indexed: 12/02/2023] Open
Abstract
Lavender essential oil (LEO) is known for its medicinal use in the development of pharmaceuticals. Further investigations were demonstrated that LEO has many biological properties including apoptosis. However, The anti-breast cancer activity and mechanism of LEO are still unclear. we aim to elucidate the elusive anti-breast cancer activity and mechanism of LEO by unveiling the intricate molecular targets that it engages with, thereby priming it for effective therapeutic intervention against breast carcinoma. In this paper, we extracted LEO from lavender and analyzed it's chemical constituents by using hydro-distillation and gas chromatography-mass spectrometry (GS-MS/MS) method, respectively. The active components against breast cancer and it's molecular targets were selected and biological process, molecular function, cellular component and involving pathways were evaluated via network pharmacology approach. Cell viability, apoptosis and cell cycle assay were used to evaluate anti-breast cancer effect of LEO. Employing the western blotting method to validate target protein expression following LEO treatment in vitro. We found the 21 effective components and 213 drug-disease common targets of LEO. Amoung them, 7 active components and 19 targets were identified as potential therapeutic targets. Gene ontology results revealed that the drug-disease common targets of LEO were mainly distributed in membrane region, involved in peptide-tyrosine phosphorylation, and primarily associated with protein tyrosine kinase. We also found that drug-disease common targets might contribute to the regulation of PI3K-AKT signaling pathway by using KEGG pathway analysis. Besides, our study demonstrated reduced cell viability, induced apoptosis in MCF-7 and MDA-MB-231 treated with LEO while cell cycle arrest was not altered. The AKT1 expression down-regulated while PIK3CA expression was increased in both cell lines. Our findings indicate that LEO has the ability to induce apoptosis by modulating the expression of PI3K-AKT signaling pathway in these cell lines.
Collapse
Affiliation(s)
- Guzhalinuer Maitisha
- Clinical Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of Traditional Chinese Medicine, Wuhan 430061, China
| | - Junhao Zhou
- School of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan 430065, China
| | - Yan Zhao
- Clinical Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of Traditional Chinese Medicine, Wuhan 430061, China
| | - Shuxia Han
- Clinical Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of Traditional Chinese Medicine, Wuhan 430061, China
| | - Youyun Zhao
- Clinical Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of Traditional Chinese Medicine, Wuhan 430061, China
| | - Ablikim Abliz
- Department of Gastrointestinal Surgery, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of Traditional Chinese Medicine, Wuhan 430061, China
| | - Guangzhong Liu
- Clinical Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of Traditional Chinese Medicine, Wuhan 430061, China
| |
Collapse
|
2
|
Espinosa-Rodriguez BA, Treviño-Almaguer D, Carranza-Rosales P, Ramirez-Cabrera MA, Ramirez-Estrada K, Arredondo-Espinoza EU, Mendez-Lopez LF, Balderas-Renteria I. Metformin May Alter the Metabolic Reprogramming in Cancer Cells by Disrupting the L-Arginine Metabolism: A Preliminary Computational Study. Int J Mol Sci 2023; 24:ijms24065316. [PMID: 36982390 PMCID: PMC10049129 DOI: 10.3390/ijms24065316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2023] [Revised: 03/04/2023] [Accepted: 03/08/2023] [Indexed: 03/12/2023] Open
Abstract
Metabolic reprogramming in cancer is considered to be one of the most important hallmarks to drive proliferation, angiogenesis, and invasion. AMP-activated protein kinase activation is one of the established mechanisms for metformin’s anti-cancer actions. However, it has been suggested that metformin may exert antitumoral effects by the modulation of other master regulators of cellular energy. Here, based on structural and physicochemical criteria, we tested the hypothesis that metformin may act as an antagonist of L-arginine metabolism and other related metabolic pathways. First, we created a database containing different L-arginine-related metabolites and biguanides. After that, comparisons of structural and physicochemical properties were performed employing different cheminformatic tools. Finally, we performed molecular docking simulations using AutoDock 4.2 to compare the affinities and binding modes of biguanides and L-arginine-related metabolites against their corresponding targets. Our results showed that biguanides, especially metformin and buformin, exhibited a moderate-to-high similarity to the metabolites belonging to the urea cycle, polyamine metabolism, and creatine biosynthesis. The predicted affinities and binding modes for biguanides displayed good concordance with those obtained for some L-arginine-related metabolites, including L-arginine and creatine. In conclusion, metabolic reprogramming in cancer cells by metformin and biguanides may be also driven by metabolic disruption of L-arginine and structurally related compounds.
Collapse
Affiliation(s)
- Bryan Alejandro Espinosa-Rodriguez
- Universidad Autonoma de Nuevo Leon, School of Chemistry, Laboratory of Molecular Pharmacology and Biological Models, San Nicolas de los Garza 64570, Mexico; (B.A.E.-R.); (D.T.-A.); (M.A.R.-C.); (K.R.-E.); (E.U.A.-E.)
| | - Daniela Treviño-Almaguer
- Universidad Autonoma de Nuevo Leon, School of Chemistry, Laboratory of Molecular Pharmacology and Biological Models, San Nicolas de los Garza 64570, Mexico; (B.A.E.-R.); (D.T.-A.); (M.A.R.-C.); (K.R.-E.); (E.U.A.-E.)
| | - Pilar Carranza-Rosales
- Centro de Investigacion Biomedica del Noreste, Laboratory of Cell Biology, Instituto Mexicano del Seguro Social, Monterrey 66720, Mexico;
| | - Monica Azucena Ramirez-Cabrera
- Universidad Autonoma de Nuevo Leon, School of Chemistry, Laboratory of Molecular Pharmacology and Biological Models, San Nicolas de los Garza 64570, Mexico; (B.A.E.-R.); (D.T.-A.); (M.A.R.-C.); (K.R.-E.); (E.U.A.-E.)
| | - Karla Ramirez-Estrada
- Universidad Autonoma de Nuevo Leon, School of Chemistry, Laboratory of Molecular Pharmacology and Biological Models, San Nicolas de los Garza 64570, Mexico; (B.A.E.-R.); (D.T.-A.); (M.A.R.-C.); (K.R.-E.); (E.U.A.-E.)
| | - Eder Ubaldo Arredondo-Espinoza
- Universidad Autonoma de Nuevo Leon, School of Chemistry, Laboratory of Molecular Pharmacology and Biological Models, San Nicolas de los Garza 64570, Mexico; (B.A.E.-R.); (D.T.-A.); (M.A.R.-C.); (K.R.-E.); (E.U.A.-E.)
| | - Luis Fernando Mendez-Lopez
- Universidad Autonoma de Nuevo Leon, School of Public Health and Nutrition, Center for Research on Nutrition and Public Health, Monterrey 66460, Mexico
- Correspondence: (L.F.M.-L.); (I.B.-R.);Tel.: +52-81-1042-2622 (L.F.M.-L.); +52-81-8329-4000 (I.B.-R.)
| | - Isaias Balderas-Renteria
- Universidad Autonoma de Nuevo Leon, School of Chemistry, Laboratory of Molecular Pharmacology and Biological Models, San Nicolas de los Garza 64570, Mexico; (B.A.E.-R.); (D.T.-A.); (M.A.R.-C.); (K.R.-E.); (E.U.A.-E.)
- Correspondence: (L.F.M.-L.); (I.B.-R.);Tel.: +52-81-1042-2622 (L.F.M.-L.); +52-81-8329-4000 (I.B.-R.)
| |
Collapse
|
3
|
Rivera RG, Regidor PJS, Ruamero Jr EC, Allanigue EJV, Salinas MV. A network pharmacology and molecular docking approach in the exploratory investigation of the biological mechanisms of lagundi (Vitex negundo L.) compounds against COVID-19. Genomics Inform 2023; 21:e4. [PMID: 37037462 PMCID: PMC10085743 DOI: 10.5808/gi.22060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2022] [Revised: 12/27/2022] [Accepted: 02/08/2023] [Indexed: 04/03/2023] Open
Abstract
Coronavirus disease 2019 (COVID-19) is an inflammatory and infectious disease caused by severe acute respiratory syndrome coronavirus 2 virus with a complex pathophysiology. While COVID-19 vaccines and boosters are available, treatment of the disease is primarily supportive and symptomatic. Several research have suggested the potential of herbal medicines as an adjunctive treatment for the disease. A popular herbal medicine approved in the Philippines for the treatment of acute respiratory disease is Vitex negundo L. In fact, the Department of Science and Technology of the Philippines has funded a clinical trial to establish its potential as an adjunctive treatment for COVID-19. Here, we utilized network pharmacology and molecular docking in determining pivotal targets of Vitex negundo compounds against COVID-19. The results showed that significant targets of Vitex negundo compounds in COVID-19 are CSB, SERPINE1, and PLG which code for cathepsin B, plasminogen activator inhibitor-1, and plasminogen, respectively. Molecular docking revealed that α-terpinyl acetate and geranyl acetate have good binding affinity in cathepsin B; 6,7,4-trimethoxyflavanone, 5,6,7,8,3',4',5'-heptamethoxyflavone, artemetin, demethylnobiletin, gardenin A, geranyl acetate in plasminogen; and 7,8,4-trimethoxyflavanone in plasminogen activator inhibitor-1. While the results are promising, these are bound to the limitations of computational methods and further experimentation are needed to completely establish the molecular mechanisms of Vitex negundo against COVID-19.
Collapse
Affiliation(s)
- Robertson G. Rivera
- Pharmaceutical Chemistry Department, College of Pharmacy, University of the Philippines Manila, Manila, Philippines
| | - Patrick Junard S. Regidor
- Pharmaceutical Chemistry Department, College of Pharmacy, University of the Philippines Manila, Manila, Philippines
| | - Edwin C. Ruamero Jr
- Pharmaceutical Chemistry Department, College of Pharmacy, University of the Philippines Manila, Manila, Philippines
| | - Eric John V. Allanigue
- Department of Pharmacology and Toxicology, College of Medicine, University of the Philippines Manila, Manila, Philippines
| | - Melanie V. Salinas
- Safety and Medical Affairs Department, Clinchoice Inc., Fort Washington, PA 19034, USA
| |
Collapse
|
4
|
Wang S, Chen S, Wang B, Li Q, Zu J, Yu J, Ding Z, Zhou F. Screening of endophytic fungi from Cremastra appendiculata and their potential for plant growth promotion and biological control. Folia Microbiol (Praha) 2023; 68:121-133. [PMID: 35982376 DOI: 10.1007/s12223-022-00995-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Accepted: 07/21/2022] [Indexed: 11/27/2022]
Abstract
Biocontrol fungi are widely used to promote plant growth and pest control. Four fungi were isolated from Cremastra appendiculata tubers and screened for plant growth-promoting and antagonistic effects. Based on the morphological characterization and ITS, 18S rRNA and 28S rRNA gene sequencing analysis, the fungi were identified to be related to Colletotrichum gloeosporioides (DJL-6), Trichoderma tomentosum (DJL-9), Colletotrichum godetiae (DJL-10) and Talaromyces amestolkiae (DJL-15). The growth inhibition tests showed that the four isolates had different inhibitory effects on Colletotrichum fructicola, Alternaria alternata and Alternaria longipes, among which DJL-9 showed the highest inhibitory activity. Their culture filtrates (especially that of DJL-15) can also inhibit pathogens. Four isolates were positive for the production of indole-3-acid (IAA) and β-1,3-glucanase and possessed proteolytic activity but were negative for the production of iron siderophore complexes. The four fungi showed strong nitrogen fixation and potassium dissolution abilities. In addition to DJL-9 being able to solubilize phosphate, DJL-10 was able to produce chitinase and cellulase. Pot experiments indicated that the four fungi increased the germination rate of C. appendiculata and soybean seeds and increased soybean radicle growth and plant biomass. Among them, DJL-6 had a better growth-promoting effect. Therefore, we successfully screened the biocontrol potential of endophytes from C. appendiculata, with a focus on preventing fungal diseases and promoting plant growth, and selected strains that could provide nutrients and hormones for plant growth.
Collapse
Affiliation(s)
- Siyu Wang
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China
| | - Senmiao Chen
- School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China
| | - Bixu Wang
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China
| | - Qianxi Li
- School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China
| | - Jiaqi Zu
- School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China
| | - Jie Yu
- Puer Kunhong Biotechnology Company, Group C of Chamagu Town A, Simao District, Puer, Yunnan, 665000, China
| | - Zhishan Ding
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China
| | - Fangmei Zhou
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China.
| |
Collapse
|
5
|
Yin X, Li J, Hao Z, Ding R, Qiao Y. A systematic study of traditional Chinese medicine treating hepatitis B virus-related hepatocellular carcinoma based on target-driven reverse network pharmacology. Front Cell Infect Microbiol 2022; 12:964469. [PMID: 36046748 PMCID: PMC9420877 DOI: 10.3389/fcimb.2022.964469] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2022] [Accepted: 07/27/2022] [Indexed: 02/05/2023] Open
Abstract
Hepatocellular carcinoma (HCC) is a serious global health problem, and hepatitis B virus (HBV) infection remains the leading cause of HCC. It is standard care to administer antiviral treatment for HBV-related HCC patients with concurrent anti-cancer therapy. However, a drug with repressive effects on both HBV infection and HCC has not been discovered yet. In addition, drug resistance and side effects have made existing therapeutic regimens suboptimal. Traditional Chinese medicine (TCM) has multi-ingredient and multi-target advantages in dealing with multifactorial HBV infection and HCC. TCM has long been served as a valuable source and inspiration for discovering new drugs. In present study, a target-driven reverse network pharmacology was applied for the first time to systematically study the therapeutic potential of TCM in treating HBV-related HCC. Firstly, 47 shared targets between HBV and HCC were screened as HBV-related HCC targets. Next, starting from 47 targets, the relevant chemical components and herbs were matched. A network containing 47 targets, 913 chemical components and 469 herbs was established. Then, the validated results showed that almost 80% of the herbs listed in chronic hepatitis B guidelines and primary liver cancer guidelines were included in the 469 herbs. Furthermore, functional analysis was conducted to understand the biological processes and pathways regulated by these 47 targets. The docking results indicated that the top 50 chemical components bound well to targets. Finally, the frequency statistical analysis results showed the 469 herbs against HBV-related HCC were mainly warm in property, bitter in taste, and distributed to the liver meridians. Taken together, a small library of 913 chemical components and 469 herbs against HBV-related HCC were obtained with a target-driven approach, thus paving the way for the development of therapeutic modalities to treat HBV-related HCC.
Collapse
Affiliation(s)
- Xiaofeng Yin
- Department of Neurosurgery, Second Hospital of Shanxi Medical University, Taiyuan, China
- *Correspondence: Xiaofeng Yin, ; Yanan Qiao,
| | - Jinchuan Li
- Department of Neurosurgery, Second Hospital of Shanxi Medical University, Taiyuan, China
| | - Zheng Hao
- Department of Neurosurgery, Second Hospital of Shanxi Medical University, Taiyuan, China
| | - Rui Ding
- Department of Neurosurgery, Second Hospital of Shanxi Medical University, Taiyuan, China
| | - Yanan Qiao
- Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan, China
- *Correspondence: Xiaofeng Yin, ; Yanan Qiao,
| |
Collapse
|